Maturation of mHealth

Robert Istepanian of the Institute of Global Innovation at the UK's Imperial College sees clear evidence that mHealth is valuable in treating chronic diseases. However, standards, governance and integration still need work.
By HIMSS TV
05:07 PM
The rise of mHealth 2.0
There is clear evidence that mHealth is valuable in treating chronic diseases, says Robert Istepanian of the Institute of Global Innovation at the UK's Imperial College. However, standards, governance and integration still need work.
Video Player is loading.
Current Time 0:00
Duration 7:27
Loaded: 0%
Stream Type LIVE
Remaining Time 7:27
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
    • en (Main), selected
    Want to get more stories like this one? Get daily news updates from Healthcare IT News.
    Your subscription has been saved.
    Something went wrong. Please try again.